Business
Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price was in reverse today after surging more than 11% on Monday. The allogeneic cellular medicines company announced a trial update to its rexlemestrocel-L drug.
At the closing bell, Mesoblast shares finished the day down 8.68%…
Continue Reading
-
Business23 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Business19 hours agoASX 200 plunges as US tariffs fall-out continues
-
Noosa News19 hours agoPolice to get on-the-spot protection powers for DV victims
-
Noosa News15 hours agoBrisbane Doctor jailed for supplying drugs worth millions to bikies